Dr Jose Montoya, Live Webcast from Stanford, Jan 18th 7PM PST

M

MErmaid

Guest
http://events.stanford.edu/events/743/74379/

You may opt to attend the lecture in person at Hoover Pavilion (requires registration) OR choose to watch the live webcast.

Presented by Stanford Health Library

Chronic Fatigue Syndrome (CFS) is a complex, multifaceted disorder characterized by extreme fatigue and a host of other symptoms that can worsen after physical or mental activity, but do not improve with rest. This presentation will discuss clinical implications of recent scientific reports that are pinning down the development of this disease. Treatment implications and future avenues for research will also be discussed.

You can watch this program via a live webcast at 7pm PST at the following web link:https://stanfordvideo.stanford.edu/healthlibrary

Speaker: Jose Montoya, MD

WHEN:
Thursday, January 18, 2018
7:00 pm – 8:30 pm
WHERE:
Stanford Health Library, Hoover Pavilion, Suite 201, 211 Quarry Rd., Palo Alto, CA 94304
ADMISSION:
No Fee. To register call 650-498-7826
 
Last edited:
Did anyone remember to order take out pizza? :emoji_pizza:

Mine with Gluten Free crust please.

How about beer? Is it still sitting out my car trunk, cause I was too tired to bring it inside earlier?

Think I will hold off on the pastel colored unicorn poop Frosty swirls.

I am making a run to the store, does anyone want me to pick anything?
 
Due to a bad internet connection, I saw relatively little of the presentation.

However, I did see a section in which Dr. Montoya mentioned that a paper involving an HLA test was "positive."

If you look at the Ongoing Research page here and scroll down to the Published section, it says:
SUBGROUPING CFS PATIENTS BY GENETIC AND IMMUNE PROFILING
Analysis of human leukocyte antigen (HLA) types in ME/CFS patients, which regulates the human immune system. Publication pending of this initial research.
Click to expand...
[This section also points to the cytokine/severity paper published last summer, but I'm pretty sure that this is a separate study.]

So, it sounds like they may have found a genetic similarity in the human leukocyte antigen (HLA) complex of at least some ME/CFS patients.

According to Wikipedia:
HLA types are inherited, and some of them are connected with autoimmune disorders and other diseases. People with certain HLA antigens are more likely to develop certain autoimmune diseases, such as type I diabetes, ankylosing spondylitis, celiac disease, SLE(systemic lupus erythematosus), myasthenia gravis, inclusion body myositis, Sjögren syndrome, and narcolepsy.
Click to expand...

The presence of certain human leukocyte antigens can increase your risk of developing various conditions, but it does not mean that you will develop them.

I could be wrong, but it sounds like they may have found preliminary evidence of a genetic predisposition for ME/CFS, at least in some patients.
 
Last edited:
Milo said:
For a brief moment Dr Montoya expressed his desire to have a clinical trial with Tofacitinib. I forgot his reasoning but you can find out about the drug here
Click to expand...
@Milo - I'm glad you mentioned his referencing Tofacitinib. He mentioned it at the last CFSAC meeting and about trialling it, but I could not understand the name of the drug through his accent. I posted a question for the video interview with Dr. Montoya on S4ME and am eager to see if he discusses in more detail why this drug peaks his interest.
 
You must log in or register to reply here.
Back
Top Bottom